Martin Christopher Nathan bought ORKA

December 11, 2025 · Form 4 insider transaction

Martin Christopher Nathan bought 35,000 shares of Oruka Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction

Acquired (buy-side)

35,000

Price

$0.00

Total value

N/A

InsiderMartin Christopher Nathan

RoleDirector

CompanyOruka Therapeutics, Inc. (ORKA)

SecurityStock Option (right to buy)

Transaction codeA — Grant or award

Transaction dateDecember 11, 2025

Filing dateDecember 11, 2025

Shares owned after35,000

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

The option vests as to 1/36 of the underlying shares monthly from December 11, 2025.

View the original Form 4 on SEC EDGAR